¡i±þ¯}¯T¨C©P¬P®y¹B¶Õ¡j´£¨Ñ¦U¬P®y¾ãÅé¹B¶Õ¤ÀªR¡B·í¶g¶·ª`·N¨Æ¶µ¡C¶q¨­¬°12¬P®y¥´³y¥»¶g¬P®y³Ì¨Î¦æ¨««ü«n¡I ¡i­Òij+ ¹q¤l³ø¡j¶Ç»¼¤Hª«¬G¨Æ¡AÂê©wªx±Ð¨|¡BªÀ¥ø¡Kµ¥»â°ì¡A³z¹L¥L­Ì¬°ªÀ·|¥I¥X¬G¨Æ¡A´Á«Ý¤Þ°_§ó¦h¦@»ï¡C
¡¹ µLªk¥¿±`ÂsÄý¤º®e¡A½Ð«ö³o¸Ì½u¤W¾\Ū
·s»D  °·±d  udn³¡¸¨®æ  
2025/02/27 ²Ä586´Á  |  ­q¾\¡þ°h­q  |  ¬Ý¾ú¥v³ø¥÷  |  ¥_¬ü´¼Åvºô¯¸
 
 
 
 
±M§QµûªR Core Wireless v. Apple ®×¯d¤UªººÃ°Ý¡G¼Ð·Ç¥²­n±M§Q³Ì¨Î«Å§i®É¾÷¬°¦ó¡H
   
ªk³W¶D³^ °Ó¼Ð³QºM¾P¡A¬O¦]¬°¥Ó½Ð¤F±M§Q¡H2025¦~¬ü°êCeramTec®×
   
²`¤J³ø¾É ¤A¤ºñQÓiÃþ§Ü¥Í¯ÀÃĪ«¤§Åã¦Ó©ö¨£©Ê±´°Q¡GMerck Sharp & Dohme Corp. v. Hospira, Inc.(Fed. Cir. 2017)
   
¬ãµo³Ð·s 2024¦~¤H¤u´¼¼z³Ð§ë²{ªp¤Î¥¼¨ÓÁͶÕ
   
 
Core Wireless v. Apple ®×¯d¤UªººÃ°Ý¡G¼Ð·Ç¥²­n±M§Q³Ì¨Î«Å§i®É¾÷¬°¦ó¡H
±i§J¥­¢¬ÂE®ü¤¤¥¡´¼ÅvÁ`³B¡@§Þ³N¸g
CAFC»{¬°2018¦~CORE WIRELESS V. APPLE ®×[1]ªº¥D­nª§Ä³¦b©óNOKIA¬O§_¦]¬°©µ¿ð«Å§i¦ÓÀò±o¤£¤½¥­§Q¯q? ¦¹®×¦b2019¦~§ó¼f®É¦a°|±Ä¯ÇAPPLE±M®a·N¨£¡A»{¬°¦pªGNOKIAªº«Å§i¨S¦³³Q©µ¿ð¡A¦³¥i¯à¨tª§±M§Q©Ò¹ïÀ³ªº§Þ³N´N¤£·|³QGPRS¼Ð·Ç©Ò²[»\¡Cµ§ªÌ·Q±´°Q¦¹®×¬O§_¦³¼vÅT¨ì¥D­n5G SEP«ù¦³ªÌªº«Å§i®É¾÷¡H

Äá¼v¡G¥_¬ü´¼Åv³ø¡@¿càà

Nokia©ó1997¦~11¤ë¦VETSI (European Telecommunications Standards Institute¡A¼Ú¬w¹q«H¼Ð·Ç¨ó·|) ´£¥X¤F¤@­Ó¦³Ãö¤â¾÷»P°ò¦a¥x¦P¨Bªº¤èªk¡A¦P®É¤]¦bªâÄõ¥Ó½Ð¤F¨tª§±M§Q®a±Úªº²Ä¤@­Ó¥Ó½Ð®×¡A¨Ã©ó2002¦~7¤ë§¹¦¨¤FETSI«Å§i¡C©ó2019¦~Core Wireless v. Apple®×§ó¼f®É¡A¦a°|»{¬°Nokia¦]¦b´£¥æ±M§Q¥Ó½Ðªº¦P®É¥¼¦VETSI«Å§i¦Ó³Q»{©w¦³misconductªº¦æ¬°¡A¥BNokia¦³±q¨ämisconduct¦æ¬°Àò±o¤£¤½¥­§Q¯q¡C±q¦¹®×©Ò­l¥Í¥Xªº¤@­Ó°ÝÃD¬O: ­Y¥HÀu¥ýÅv¤é¬°°ò·Ç¡A¨ì©³©µ¦h¤[¥¼¦VETSI«Å§iºâ¡u¿ð¡v?

Core Wireless v. Apple ®×¥ó­I´º

Nokiaµo©ú¤H©ó1997¦~11¤ë¦VETSI´£¤F¤@­Ó¦³Ãö¤â¾÷»P°ò¦a¥x¦P¨Bªº¤èªk¡A¦P®É¤]¦bªâÄõ¥Ó½Ð¤F¨tª§±M§Q¡A1998¦~1¤ëETSI±Ä¥Î¤FEricssonªº´£®×¡A¨ä¤¤¦³¥]§t»PNokia¬Û¦Pªº¦P¨B¤èªk¡A°ß¤@ªº®t§O¬OEricsson§â³o­Ó¤èªk¦C¬°optional¡C2002¦~7¤ëNokia§¹¦¨¤F«Å§i¡C2011¦~9¤ëNokia±N¨tª§±M§QÂàÅýµ¹Core Wireless¡C2014¦~9¤ë Core Wireless¨Ï¥Î¨tª§±M§Q¦b¬üªF¼w¦{¦a°|´£°_«IÅv§i¶D¡C¦a°|»{¬°Apple¦³«IÅv¥B¨tª§±M§Q¬O¦³®Ä¡A¨Ã°ò©ó¥H¤U¤TÂI»{¬°implied waiver (Àq¥Ü±óÅv¡G±q·í¨Æ¤Hªº¦æ¬°¤¤¥i¥H¦X²z±À©wªºÅv§Q©ñ±ó) ¤£¦¨¥ß¡C

  1. Nokia©ó1997¦~ªº´£®×³Q»é¦^¤F¡A©Ò¥H¨S¦³«Å§i¸q°È;
  2. ªâÄõ¨tª§±M§Q¦b2002¦~«Å§i«eÁÙ¥¼ÀòÃÒ;
  3. Apple¨S¦³´£¥XÃÒ¾ÚÅã¥Ü1998¦~Nokia¨S¦³°µ«Å§i»Pimplied waiver¶¡¬O¦³Ãöªº¡C

Apple¹ï¦a°|§P¨Mµ²ªG¤£ªA´£°_¤W¶D¡C¤W¶Dªk°|°w¹ï¨tª§±M§Q¡A´£¥X¤FNokia¬O§_¦³«Å§i¸q°È¥H¤ÎNokia¬O§_¦³¹H¤Ï¦¹¸q°ÈªºÄ³ÃD¡C¤W¶Dªk°|¹ï¦a°|ªº¤T­Ó¥ß³õ¬Ò¦³¤£¦P·N¨£¡C

  1. ´£®×³Q»é¦^¤£¥Nªí¤£¥Î«Å§i¡A¦]¬°ETSI IPR Policy¬O¡§might be¡¨ essential;
  2. ¨Ã¨S¦³ÃÒ¾ÚÅã¥ÜETSI IPR Policy±Æ°£¥¼ÀòÃҥӽЮ׶i¦æ«Å§i¡F

    implied waiver doctrine¨Ã¨S¦³­n¨D¹³Apple³o¼Ëªº²Ä¤T¤è¥h´£¨Ñ±M§QÅv¤Hªº¦æ¬°»Pimplied waiver¶¡ªºÃÒ¾Ú¡C

¤W¶Dªk°|±N¦¹®×µo¦^¦a°|§ó¼f¡A¨Ã­n¨D¦a°|ª`·NNokia¬O§_¦³¡§unfairly benefited from its wrongful actions¡¨ªº±¡§Î¡C¦]¦¹¦a°|¶·¤F¸ÑNokia¬O§_¦³egregious misconductªº¦æ¬°¥H¤Î©µ¿ð«Å§i¬O§_´ÀNokia±a¨Ó¤£¤½¥­ªº§Q¯q¡C­º¥ý¡A¦a°|°ò©ó¥H¤U¨âÂI»{¬°Nokia¨S¦³egregious misconduct¡C

  1. Nokia¥u¬O©µ¿ð«Å§i¡A¨Ã¨S¦³¦pIntellect Wireless v. HTC®×¤¤¦³µê°²³¯­zªº´Û¶B¦æ¬°;
  2. Nokiaªº«Å§iÁöµM©µ¿ð¤F¥|¦~¡A¦ý¨S¦³¦pQualcomm v. Broadcom®×¤¤¦³¤½¥q»P­û¤u¦X¿Ñ©¿²¤«Å§i¸q°Èªº´Û¶B¦æ¬°¡C

¦a°|°ò©ó¥H¤U¨âÂI»{¬°Nokia¦³±q¨ämisconductÀò±o¤£¤½¥­§Q¯q¡C

  1. ¦a°|»{¬°¨tª§±M§Q¬OGPRS SEP¡AµLªk³Q°jÁצ]¦¹¥iÂÇ¥H¦¬¨úÅv§Qª÷¡A¦ÓNokia¬O§_¨Ì¾ÚFRAND¨Ó¦¬Åv§Qª÷«Dinequitable benefitªº­«ÂI¡C³o¬O¦]¬°¦pªG¸Ó±M§Q¤£¬OSEP¡A²Ä¤T¤è¥i¯à´N¤£»Ý­nÀò±o³\¥i¡A¦¹®ÉµL½×³\¥i¬O§_²Å¦XFRAND±ø´Ú´N¤£¬O­«­nªº¨Æ¡C
  2. ¦a°|±Ä¯ÇApple±M®aªº·N¨£¡A»{¬°¦pªGNokiaªº«Å§i¨S¦³©µ¿ð¡A¦³¥i¯à¨tª§±M§Q´N¤£·|³Q¯Ç¶iGPRS¼Ð·Ç¡C³o¬O¦]¬°ETSI «e¸³¨Æ·|¥D®u Michael Walker ³Õ¤h(GSM/GPRS¼Æ¦ì³q°T¦­´ÁªºÃöÁä¤Hª«¤§¤@[2])ÃÒ¹êETSI ·|­û¦³°Ê¾÷¿ï¾ÜµL»Ý³\¥i¦¨¥»ªº§Þ³N¸Ñ¨M¤è®×¡C

¦U®a¼Ð·Ç±M§Q«Å§i®É¾÷¾ã²z(2024)

µ§ªÌ¦ÛQualcomm¡BHuawei¡BEricsson¤ÎSamsung©ó2024¦~10¤ë21¤é¦Ü2024¦~11¤ë20¤é¶¡©Ò¤½¶}ªº¬ü°ê¥Ó½Ð®×[3]¤¤¡A¥HV2X©ÎNTN¬°ÃöÁä¦r¥h¬d¸ß¥þ¤å«á¦¬¶°¨ì¦h½g5GÃöÁp®×¡A¨Ã¦Û³o¨Ç5GÃöÁp®×¤¤¾ã²z¥X¤Uªí1¡C

ªí1. ¥D­n5G SEP«ù¦³ªÌªº«Å§i®É¾÷(2024)¡F±i§J¥­¾ã²z»sªí[4]

ªí1¾ã²z¤F4®a¥D­n5G SEP«ù¦³ªÌªº«Å§i®É¾÷¡A¥HQualcomm¬°¨Ò¡A¦@¦³160½g5GÃöÁp®×¡A¦Ü¤µ¦³46½g³Q«Å§i¹L¡C³o46½g¥]§t¤F22½gÀu¥ýÅv¤é¤¶©ó2023¦~4¤ë21¤é¦Ü2023¦~5¤ë20¤éªº¤½¶}®×¡A¥H¤Î18½gÀu¥ýÅv¤é¸û³o22½g¤½¶}®×¬ù¦­2¦~ªºPCT®×¡A¥H¤Î6½gÀu¥ýÅv¤é¸û³o22½g¤½¶}®×¬°¦­ªºCA (³sÄò®×¡Acontinuation application) ©ÎDA (¤À³Î®×¡Adivisional application) ®×¡CHuawei¡BEricsson¤ÎSamsung«h¦U¦³82/47/44½g5GÃöÁp®×¥H¤Î16/23/8½g«Å§i®×¡CQualcomm¡BHuawei¤ÎEricsson³o¤T®a¤½¥q¬Ò©óÀu¥ýÅv¤é«á´N³°Äò¦³«Å§i®×¡A³Ì¦­ªº«Å§i®×¤À§O¬°¶ZÀu¥ýÅv¤é4/2/7­Ó¤ë«á«Å§i¡ASamsung«h¬O¶ZÀu¥ýÅv¤é20­Ó¤ë«á¤~¶}©l¦³«Å§i®×¡C¹Ï1¬°¦U¤½¥q«Å§i®×¼Æ¶qv. ©µ¿ð[5]ªº¥Ü·N¹Ï¡C

¹Ï1. ¥D­n5G SEP«ù¦³ªÌ«Å§i®×¼Æ¶qv. ©µ¿ð(2024)¡F±i§J¥­¾ã²z»s¹Ï

ªí2. ¥D­n5G SEP«ù¦³ªÌ«Å§i®×¼Æ¶qv. ©µ¿ð (2024)¡F±i§J¥­¾ã²z»sªí

¹Ï1¤Îªí2¾ã²z¤F4®a¥D­n5G SEP«ù¦³ªÌ«Å§i®×¼Æ¶qv. ©µ¿ð¡A³o°Ï¶¡²Î­pªº«Å§i®×¦³6¦¨¬O¦b¶ZÀu¥ýÅv¤é12~24­Ó¤ë¶¡§¹¦¨«Å§i¡CSamsungªº«Å§i®×³£©ó¶ZÀu¥ýÅv¤é24­Ó¤ë«e§¹¦¨¡C¦ÓHuawei US20240365263A1³o½gCA®×³Ì¦­Àu¥ýÅv¤é¬°2016-08-11¡A¨ä®a±Úªº³Ì«á¤@¦¸[6]«Å§i¤é¬°2023-04-13¡A©µ¿ð80­Ó¤ë¡CEricsson US20240357641A1³o½gCA®×¨ä³Ì¦­Àu¥ýÅv¤é¬°2018-05-11¡A¨ä®a±Úªº«Å§i¤é[7]¬°2023-10-20¡A©µ¿ð65­Ó¤ë¡C

¡i¥»¤å¥¼§¹¡A§¹¾ã¤º®e½Ð¨£¡m¥_¬ü´¼Åv³ø¡n374´Á¡G±M§Q®v¤½·|ªº¨Ï©R»P¾UÅÜ¡G±M³X·s¥ô²z¨Æªø¯³«ØÃСj

¡°¦p±ýÂà¸ü¥»¤å¡A½Ð»P¥_¬ü´¼Åv³øÁpµ¸

 
°Ó¼Ð³QºM¾P¡A¬O¦]¬°¥Ó½Ð¤F±M§Q¡H2025¦~¬ü°êCeramTec®×
°K¦p³®¢¬¥xÆW±M§Q®v
°Ó¼Ðªº®Ö¤ß¥\¯à¬°¿ëÃÑ°Ó«~©ÎªA°Èªº¨Ó·½¡A¨¾¤î®ø¶OªÌ²V²c»~»{¡C¥Ñ©ó°Ó¼ÐÅv¥i¤£Â_®i©µ¡A¤£¹³±M§Q³Ì¦h¥u¦³20¦~ªº¦³®Ä´Á¶¡¡A¦]¦¹­Y¤@­Ó¥\¯à©Ê³]­p³Qµù¥U¬°°Ó¼Ð¡A´N·N¨ýµÛ½á¤©¤F°Ó¼ÐÅv¤H¹ï¸Ó¥\¯àªº¥Ã¤[©ÊÃbÂ_¡C³o·|ªýê¨ä¥LÄvª§ªÌ§Q¥Î¤wÄݩ󤽻â°ìªº§Þ³N¶i¤J¥«³õ¡A¦Ó³o±N·|ªýê³Ð·s¡A³Ì²×·l®`®ø¶OªÌ§Q¯q¡A¦]¦¹¦U°ê¬Ò¤£¤¹³\±N¥\¯à©Ê¯S¼x³Q®³¨Ó¥Ó½Ð°Ó¼Ð¡C

®×¥ó­I´º¡G¿W¯Sªº¯»¬õ¦â§÷®Æ

¦b1990¦~¥N¡A¼w°ê§Þ³N³³²¡¤½¥qCeramTec GmbH¬ãµo¥X¤@ºØ·sªº§÷®Æ¡A¤]´N¬O®ñ¤Æèp¼W¶´®ñ¤Æ¾T(zirconia-toughened alumina, ZTA)¡C¨Ã¦b¦¹³³²¡§÷®Æ¤¤²K¥[¤Ö¶q®ñ¤Æ»Ì¥H§ïµ½©Ê¯à¡A¨Ã¦b1998¦~Àò±o¦¹§Þ³Nªº¬ü°ê±M§Q (US5,830,816)¡C³oºØ³³²¡©Ò§e²{ªº¯»¬õÃC¦â¬°²K¥[®ñ¤Æ»Ì¦Ó²£¥Íªº°Æ²£ª«¡C

¹Ï1. 2025¦~¬ü°êCeramTec®×¤§ª§Ä³¨Ó¦Û¹Ï¤¤¤H¤uÆbÃö¸`¨t²Î¤¤¯»¬õ¦âªº³³²¡¥ó¡F¹Ï¤ù¨Ó·½¡GCoorsTekªºµªÅGª¬ (PRINCIPAL BRIEF OF APPELLEE)

ÁöµM¨ä«á¥Ñ©ó»s³y§Þ³Nªº´£¤É¡A¨Ï±oµL»Ý²K¥[®ñ¤Æ»Ì´N¥i¥HÀò±oÃþ¦üªº©Ê¯à¡A¦ýCeramTecµo²{¡A«È¤á¤w¸g±N¯»¬õ¦â»P¨ä²£«~ªº«~½è¤ÎÁnÅAÁpô°_¨Ó¡A§Î¦¨¤F¿W¯Sªº¥«³õÀu¶Õ¡A©Ò¥HCeramTec¦b2012¦~¬°¯»¬õ¦âªº³³²¡ÆbÃö¸`¥Ó½Ð¤F°Ó¼Ð¡A¦Ó±M§Q«h¦b2013¦~¹L´Á¡C

¹Ï2. CeramTec ©Ò¥Ó½Ðªº°Ó¼Ð¡F¸ê®Æ¨Ó·½¡GCAFC§P¨M®Ñ¡C

¦bCeramTec ªº±M§Q¹L´Á«á¡A¥t¤@¶¡¼t°ÓCoorsTek¤]¶}©l³c°â²K¥[®ñ¤Æ»Ìªº³³²¡§÷®Æ¡C¥»®×§Y¬O·½¦ÛCoorsTek¹Á¸Õ¥hºM¾PCeramTecªº°Ó¼Ð¡A²z¥Ñ¬O¯»¬õ¦â¬O¥\¯à©Êªº¡A¦]¦¹¤£²Å¦X°Ó¼Ð«OÅ@ªº­n¥ó¡C­È±oª`·Nªº¬O¡ACoorsTek¨ä¹ê¤]»{¬°²K¥[®ñ¤Æ»Ìªº§÷®Æ¦b«~½è©Î¥\¯à¤W¨S¦³®t²§¡A¦ý¥L­Ì¤´µM§Æ±æ¯à³c°â¯»¬õ¦âªº²£«~¡A­I«á­ì¦]¦ÛµM¬O¦]¬°¯»¬õ¦âªº³³²¡ÆbÃö¸`¹ï«È¤á¨Ó»¡¡A¨ã¦³¿W¯Sªº§l¤Þ¤O¡C

°Ó¼ÐÅv¤HCeramTec«h¥D±i¡A¦Û¤v¥H«e¤]¬Û«H²K¥[»Ì¥i¥H§ïµ½ZTA³³²¡¡A¦ý«á¨Óµo²{³o¬O¿ù»~ªº¡CµM¦Ó¬ü°ê°Ó¼Ðµû¼f¤W¶D©e­û·| (TTAB) ¤´®Ú¾ÚMorton-Norwich®×ªº¥|¦]¯À[1]¡A§P©w¯»¬õ¦âªº³³²¡ÆbÃö¸`¨ã¦³¥\¯à©Ê¡A¨ÃºM¾P¤F¨ä°Ó¼Ð¡CCeramTec¦]¦¹¤W¶D¦Ü¬ü°êÁp¨¹¨µ°j¤W¶Dªk°|(CAFC)¡C

CeramTecªº¯»¬õ¦â°Ó¼Ð¬O§_¦³¥\¯à©Ê¡H

¦b¤W¶D¶¥¬q¡ACAFC¦P¼Ë¨Ì¾ÚMorton-Norwich¥|¦]¯À¶i¦æ§PÂ_¡G

¦]¯À¤@¡]¬O§_¦³´¦ÅS¸Ó¯S¼xÀuÂIªºµo©ú±M§Q¡^¡G

CeramTecÁnºÙ¡A¨tª§±M§Q¥¼©ú½T´¦ÅS¯»¬õ¦âªºZTA³³²¡¡]¨tª§±M§Q¥u»¡¥i¥H²K¥[»Ì¡A¦ý¨S¦³´£¨ì·|²£¥Í¯»¬õ¦âªº³³²¡¡^¡A¤]¨S¦³¯A¤ÎÆbÃö¸`³¡¥ó¡]¥u´¦ÅS¤FZTA ³³²¡§@¬°¤Á³Î¤u¨ãªº­ì©l¥Î³~¡^¡A¨Ã«ü¥XTTABªº§PÂ_»P³Ì°ªªk°|¦bTrafFix¤@®×ªº±Ð¥Ü¤£¦P¡C

µM¦ÓCAFCªí¥Ü¡A³Ì°ªªk°|¦bTrafFix¤@®×¤¤ªº±Ð¥Ü¬°¡Gµo©ú±M§Q¬O±Â¤©µ¹¡u¿W¯S¥B¦³¥Îªº¡vªºµo©ú¡A¦]¦¹¬OÃÒ©ú¯S¼x¨ã¦³¥\¯à©Êªº¦³¤OÃÒ¾Ú(strong evidence that the features therein claimed are functional.)¡C¤Ï¤§¡ATrafFix®×¨S¦³´£¤Î±M§Q¥²¶·©ú½T´¦ÅS¸Ó¯S¼x¨ã¦³¥\¯à©Ê¡A¤~¯à¦¨¬°¯S¼x¨ã¥\¯à©ÊªºÃÒ¾Ú¡CTrafFix¤]¨S¦³»¡¯S¼x¥²¶·¥Î©ó±M§Q¤¤´y­zªº°Ó«~¡]³³²¡ÆbÃö¸`¡^¡C´«¨¥¤§¡ACeramTecªº¥D±i¬O°ò©ó¹ïTrafFix¤@®×ªº¿ù»~¸ÑŪ¡C¥t¥~¡ACeramTec¥ý«e¤w¸g©Ó»{¡G

(I) ²K¥[»Ì·|¨ÏZTA³³²¡Åܦ¨¯»¬õ¦â¡F

(II) ¨ä²£«~¹ê¬I¤F¦Ü¤Ö¤@¶µ¨tª§±M§Qªº½Ð¨D¶µ¡C

¦ÓTTAB¤]¦Ò¼{¤F¨tª§±M§Qªº»¡©ú®Ñ¤Î¼f¬d¾úµ{¡A¨Ò¦p¦b±M§Q»¡©ú®Ñ¤¤´£¤Î¡u²K¥[»Ì­º¦¸¨Ï±o¥H«eµLªk¹ê²{ªºµw«×­È¦¨¬°¥i¯à¡v(the addition of chromia makes it possible for the first time to achieve hardness values such as have not previously been achieved)¡C

¥t¥~¡AÁöµMCeramTec±j½Õ±M§Q¯S¼x³Q»{¬°¦³§Q©ó»{©w°Ó¼Ð¨ã¦³¥\¯à©Êªº­ì¦]¬O¡u¤½²³¦b±M§Q´Á­­©¡º¡«áÀ³¸Ó¦Û¥Ñ¨Ï¥Î³o¨Ç¯S¼x¡v¡A¦Ó¥u­n¤£»s³y¡u¯»¬õ¦â²£«~¡v¡A¤½²³¥»´N¥i¥H¦Û¥Ñ¨Ï¥ÎCeramTecªº¹L´Á±M§Q¡CCAFC¦P¼Ëªí¥Ü³o¼Ëªº»¡ªk¯Ê¥F»¡ªA¤O¡C³Ì°ªªk°|¦bQualitex¤@®×¤¤¤w¸gªí©ú¡A¤½²³¦b±M§Q´Á­­©¡º¡«á¡A¡u¥i¥H¦Û¥Ñ¨Ï¥Î¸Ó³Ð·s¡v(free to use the innovation)¡A¦Ó¤£¶È¶È¬O¸Ó³Ð·sªº¤@³¡¤À¡C

¦]¯À¤G¡]¬O§_¦³«Å¶Ç¸Ó¯S¼xÀuÂIªº¼s§i¡^¡G

TTABµo²{CeramTec¦b¨ä¦æ¾P§÷®Æ¤Î´£¥æµ¹ FDA ªº¤å¥ó¤¤¡A³£ÁnºÙ»Ì¥i¥H¬° ZTA ³³²¡±a¨Ó¦UºØ¦n³B¡A°w¹ï³o¤@ÂI¡ACeramTec¨S¦³´£¥X²§Ä³¡C

¦]¯À¤T¡]¬O§_¦³µ¥®Äªº³]­p¡^¡G

CAFC»{¬°¡A¨S¦³ÃÒ¾Ú¯à°÷ÃÒ©ú¡A¤£¦PÃC¦âªº³³²¡ÆbÃö¸`¦b¾÷±ñ©Ê¯à¤W»PCeramTecªº²£«~µ¥®Ä¡CÁöµMCeramTecÅGºÙ¡AÄvª§¼t°Ó«Å¶Ç¤£§t»Ìªº¥Õ¦â³³²¡¦b¥\¯à¤WÀu©óCeramTecªº¯»¬õ¦â³³²¡¡C¦ýCAFC»{¬°³o¼Ëªº»¡ªk¬O¦³ª§Ä³ªº¡A¥B¨S¦³³QÃÒ¾Ú©Ò¤ä«ù¡A¦]¦¹TTAB°w¹ï¦¹¦]¯Àªº¤¤©Ê§P©w¤]¬O¥¿½Tªº¡C

¦]¯À¥|¡]¬O§_¦³»s³y®Ä²v©Î¦¨¥»ªºÀuÂI¡^¡G

ÁöµMCeramTec»{¬°²K¥[»Ì´£°ª¤F³³²¡²£«~ªº»s³y¦¨¥»¡A¦ýCoorsTek´£¥XÃÒ¾ÚÃÒ©ú¡A¥Í²£¯»¬õ¦â¤Î¥Õ¦â³³²¡ªº¦¨¥»¡u«D±`¬Û¦ü¡v¡C¥Ñ©óÃÒ¾Ú¬Û¤¬¥Ù¬Þ¡ACAFC»{¬°TTAB»{©w¸Ó¦]¯À¬°¤¤©Êªº§PÂ_¥ç¬O¦X²zªº¡C

¹êÅç¸ê®ÆµLªkÃÒ©ú¯S¼x¤£¨ã¥\¯à©Ê

¦b»P¥»®×¬ÛÃöªº¼w°ê¶D³^¤¤¡A¶i¦æ¤F´X¶µ¹êÅç¡C¬ã¨s¾÷ºcµo²{¡A²K¥[¤£¦P§t¶qªº»Ì¡]­«¶q¦Ê¤À¤ñ¬° 0.0¡B0.1¡B0.3 ©M 0.5%¡^¹ï³³²¡²£«~ªºµw«×©Î­@¿i©Ê¨S¦³¼vÅT¡C

¡i¥»¤å¥¼§¹¡A§¹¾ã¤º®e½Ð¨£¡m¥_¬ü´¼Åv³ø¡n374´Á¡G±M§Q®v¤½·|ªº¨Ï©R»P¾UÅÜ¡G±M³X·s¥ô²z¨Æªø¯³«ØÃСj

¡°¦p±ýÂà¸ü¥»¤å¡A½Ð»P¥_¬ü´¼Åv³øÁpµ¸

 
¤A¤ºñQÓiÃþ§Ü¥Í¯ÀÃĪ«¤§Åã¦Ó©ö¨£©Ê±´°Q¡GMerck Sharp & Dohme Corp. v. Hospira, Inc.(Fed. Cir. 2017)
³¢§ÊÀÚ¢¬±M§Q®v
¦bÁ{§É¤W¸g±`¨Ï¥Î§Ü¥Í¯À¨ÓªvÀø·P¬V¯g¡A¦ý¦b¬ü°êÃĪ«±M§Q¶D³^¤¤¡A¯A¤Î§Ü¥Í¯ÀÃĪ«¤§§P¨M«o¸û¤Ö¨£¡C¦]¦¹¡A¥»¤åÀÀÂǥѻP§Ü¥Í¯ÀÃĪ«¬ÛÃöªº¬ü°ê§P¨MMERCK SHARP & DOHME CORP. V. HOSPIRA, INC. (FED. CIR. 2017) [1]¨Ó±´°QÃö©ó¤A¤ºñQÓiÃþ§Ü¥Í¯ÀÃĪ«¤§Åã¦Ó©ö¨£©ÊijÃD¡C

Äá¼v¡G¥_¬ü´¼Åv³ø¡@§õ²Q½¬

¦è¤¸1928¦~¡A¨È¾ú¤s¤j¡P¥±µÜ©ú (Alexander Fleming) ±Ð±Â¦b­Û´°¸t°¨§Q¨ÈÂå°| (St Mary¡¦s Hospital London) ªº¹êÅç«Ç¤¤Æ[¹î¨ìÅðµß¹ï¸²µå²yµß¨ã¦³µõ¸Ñ§@¥Î (lysis) ¡A¸g¹L¶i¤@¨BªºÅðµß°ö¾i«á¡A¥±µÜ©ú±Ð±Âµo²{¤F¥i¥H¹ï§Ü²Óµßªºª«½è¡A¦]¬°¸Óª«½è·½©óÂI«CÅð (Penicillium notatum) ¡A¬G¨ä±N¤§©R¦W¬°«CÅð¯À (Penicillin) ¡A«K¶}±Ò¤F§Ü¥Í¯Àªº®É¥N[2]¡C

®×¥ó­I´º

¥»®×³Q§i»®¤hºÍ (Hospira, Inc.) ¾Ç¦WÃļt¦]¬°¦V¬ü°ê­¹«~ÃĪ«ºÞ²z§½ (FDA) ´£¥X¤F§Ü¥Í¯ÀÃĪ«Invanz —û (¤Ì¥L°ö«n¡AErtapenem) ªº¾Ç¦WÃij\¥i¤§Â²©ö·sÃĤW¥«µ{§Ç (ANDA) ¡C­ì§iÀq¨FªFÃļt (Merck Sharp & Dohme Corp.) ©ó¬O¦V¬ü°ê¼w©Ô¥Ë¦{¡]the District of Delaware¡^ªºÁp¨¹¦a¤èªk°|´£¥X±M§Q«IÅv¶D³^¡A¥D±i³Q§i»®¤hºÍ¾Ç¦WÃļt«I®`¤F¨tª§±M§Qªº¥Ó½Ð±M§Q½d³ò¡A»®¤hºÍ¾Ç¦WÃļt«h¥D±i­ì§iÀq¨FªFÃļtªº¨tª§±M§Q¥Ó½Ð±M§Q½d³ò¦]Åã¦Ó©ö¨£¦ÓµL®Ä¡C¦a¤èªk°|»{©w»®¤hºÍ¾Ç¦WÃļt«IÅv¡A±©¨tª§±M§Q¦]Åã¦Ó©ö¨£¦ÓµL®Ä¡A­ì§iÀq¨FªFÃļt¤£ªA§P¨M¡A©Ò¥H´£¥X¤W¶D¡C

§Ü¥Í¯ÀÃĪ«¤Ì¥L°ö«n

¥±µÜ©ú±Ð±Â©Òµo²{ªº«CÅð¯À(¹Ï1)¬O¤@ºØ¨ã¦³¤A¤ºñQÓi(£]-lactam)ºc³yªº§Ü¥Í¯ÀÃĪ«¡A¨ä¥L¨ã¦³¤A¤ºñQÓiºc³yªº§Ü¥Í¯À«h¨Ò¦p¡GÀYÌUµß¯ÀÃþ§Ü¥Í¯À[3](cephalosporins¡A¹Ï2)©Î¤Ì¥L°ö«n(¹Ï3)¡C

¤Ì¥L°ö«nªº¤@¯ë¨Ï¥Î¤è¦¡¬°¨C¤Ñ¤@¦¸ª`®gµ¹¤©¡A¥i±Ä¥ÎÀR¯ß¿éª`©Î¦Ù¦×ª`®g¤è¦¡¬°¤§¡C¤Ì¥L°ö«n±þµßªº§@¥Î¾÷Âà¬O§í¨î²Óµß²Ó­M¾Àªº¦X¦¨¡A¨ä¯à¼sªx©Ê¦a¹ï§Ü³\¦h­²Äõ¤ó¶§©Êµß¡B­²Äõ¤ó³±©Êµß¤Î¹½®ñµß[4]¡C

¹Ï1. «CÅð¯Àªº¥D­nºc³y¹Ï¡F¹Ï¤ù¨Ó·½¡Gºû°ò¦Ê¬ì

¹Ï2. ÀYÌUµß¯ÀÃþ§Ü¥Í¯ÀÃĪ«ªº¥D­nºc³y¹Ï¡F¹Ï¤ù¨Ó·½¡Gºû°ò¦Ê¬ì

¹Ï3. ¤Ì¥L°ö«nªº¥D­nºc³y¹Ï¡F¹Ï¤ù¨Ó·½¡Gºû°ò¦Ê¬ì

¥»®×¨tª§±M§Q

¥»®×¨tª§±M§Q¬°¬ü°ê±M§Q²Ä6,486,150¸¹ (¡¥150±M§Q) [5]¡A¦¹±M§Qªº±M§QÅv¤H¬OÀq¨FªFÃļt¡C¨tª§±M§Q¤§¥Ó½Ð±M§Q½d³òÁ`¦@¦³40¶µ¡A¥H¥Ó½Ð±M§Q½d³ò¤¤ªº²Ä21¶µ»P¥»®×³Ì¬°¬ÛÃö¡A¦C¥X¦p¤U¡G

  1. A process for preparing a final formulation product of a compound of Formula Ia(¹Ï4), or its pharmaceutically acceptable salt, or hydrates wherein, R. sup. 4, R. sup. 5, and R. sup. 6 are independently: (a) hydrogen (b) (C. sub. 1 -C. sub. 6) ¡V alkyl, or (c) alkali ¡V metal or alkali earth ¡V metal wherein the alkali ¡V metal or alkali earth ¡V metal is sodium, potassium, lithium, cesium, rubidium, barium, calcium or magnesium; comprising the steps of: (1) charging a solution of carbon dioxide source having a pH range of about 6.0 to about 12.0 into a reaction vessel; (2) adding an effective amount of a mole ratio of a base and an active ingredient into the reaction vessel containing the solution of carbon dioxide source to maintain pH at about 6.0 to about 9.0 and a temperature range of about -3. degree. C. to about 15. degree. C.; (3) lyophilizing the solution of Step (2) to yield the final formulation product of a compound of formula Ia with less than about 10 % of moisture content.

¹Ï4. ¡¥150±M§Q¥Ó½Ð±M§Q½d³ò²Ä21¶µ¤§¤Æ¾Çºc³y¡F¹Ï¤ù¨Ó·½¡G¡¦150±M§Q»¡©ú®Ñ

¡¥150±M§Q¬°¤@ºØ»s³Æ§Ü¥Í¯ÀÃĪ«¤Ì¥L°ö«ní©w²Õ¦¨¤§¤èªk±M§Q¡A¥D­n«Y¬°¤FÁקK§Ü¥Í¯ÀÃĪ«¤Ì¥L°ö«nªº¤ô¸Ñ§@¥Î (hydrolysis) »P¤G»E¦X§@¥Î (dimerization) ¡C ¥»¤å²­n±Ô­z¡¥150±M§Qªº¥Ó½Ð±M§Q½d³ò²Ä21¶µ¡A¸Ó¶µ¤¤¥D­n¥]§t¤F¤T­Ó¨BÆJ¡A²Ä¤@¨BÆJ¬°©ó·»²G¤¤¥R¶ñ¤G®ñ¤ÆºÒ (carbon dioxide) ¥H¨ÏpH­È½d³ò¦b¤j¬ù6.0¦Ü¤j¬ù12.0¡B²Ä¤G¨BÆJ¬°¥[¤JÆP (base) »P¬¡©Ê¦¨¤À (active ingredient) ¡Aºû«ùpH­È¦b¤j¬ù6.0¦Ü¤j¬ù9.0¡A¤Î·Å«×½d³ò¦b¤j¬ù-3¢J¦Ü¤j¬ù15¢J (µù¡G¦¹·Å«×½d³ò¦b¥»®×¤¤³QºÙ¤§¬°¡u§C·Å¡v¡C)¡A²Ä¤T¨BÆJ¬°±N²Ä¤G¨BÆJªº·»²G§N­á°®Àê (lyophilizing) ¥HÀò±o³Ì²×²Õ¦¨¡A¸Ó²Õ¦¨¤§¤ô¥÷(moisture)§t¶q¤p©ó¤j¬ù10%¡C

¨tª§¤èªk±M§Q¬O§_Åã¦Ó©ö¨£

¦a¤èªk°|»{©w¨tª§±M§QÅã¦Ó©ö¨£©Ò¼f°u¤§¥ý«e§Þ³N¦³¤G¡A¨ä¤@¬°¬ü°ê±M§Q5,952,323¸¹(¡¥323±M§Q)[6]¡A¥t¤@¬°PCT¤½¶}®×WO98/18800 (¤UºÙAlmarsson±M§Q) ¡C¦a¤èªk°|»{¬°¨tª§±M§Qªº¤T­Ó¨BÆJ¤w¬°¥ý«e§Þ³N©Ò´¦ÅS¡A¨ÃÂǥѸӵo©ú©ÒÄݧ޳N»â°ì¤¤¨ã³q±`ª¾ÃѪ̬°ÁקK­°¸Ñ§@¥Î (degradation) ¦h·|±Ä¨ú§C·Åªº¤â¬q¡A¦]¦¹¡A¸Ó¨Ç¨BÆJ³Q¦a¤èªk°|»{©w¶È«Y±`³W©Ê¹êÅç (routine experimentation) ¡A¬G¨tª§±M§Q¬°Åã¦Ó©ö¨£¡C

¡i¥»¤å¥¼§¹¡A§¹¾ã¤º®e½Ð¨£¡m¥_¬ü´¼Åv³ø¡n374´Á¡G±M§Q®v¤½·|ªº¨Ï©R»P¾UÅÜ¡G±M³X·s¥ô²z¨Æªø¯³«ØÃСj

¡°¦p±ýÂà¸ü¥»¤å¡A½Ð»P¥_¬ü´¼Åv³øÁpµ¸

 
2024¦~¤H¤u´¼¼z³Ð§ë²{ªp¤Î¥¼¨ÓÁͶÕ
§õ²Q½¬¢¬¥_¬ü´¼Åv³ø¡@½s¿è³¡
2024¦~¡A¥þ²y¤H¤u´¼¼z¡]AI¡^²£·~ªï¨Ó¤F¤@­Ó¾ú¥v©Êªº°ª®p¡A§ë¸ê³W¼Ò¡B¥ø·~¦ô­È¤Î§Þ³NÀ³¥Îªº¼s«×§¡³Ð¤U·s¬ö¿ý¡CÀHµÛ¥Í¦¨¦¡AIªº½´«kµo®i¡A§ë¸êªÌªº¸êª÷¤£¶È¶°¤¤©ó¤j«¬AI¤½¥q¡A¤]¶}©l´é¦VAI°ò¦³]¬I«Ø³]¡A¨Ï±oAI²£·~ªºÄvª§±qÀ³¥Î¼h©µ¦ù¨ì­pºâ¸ê·½©M´¹¤ù§Þ³N»â°ì¡C¦b³o¼Ëªº­I´º¤U¡AAI¿W¨¤Ã~ªº¼Æ¶q¿E¼W¡A¦ý¦h¼Æ¤´³B©ó°Ó·~¼Ò¦¡ÅçÃÒ¶¥¬q¡Aªí²{¥X°ª¦ô­È»P§C°Ó·~¦¨¼ô«×¨Ã¦sªº²{¶H¡C¦P®É¡AAI¥ø·~ªº¨ÖÁʬ¡°Ê¨Ì¬¡ÅD¡A¼Ú¬w¥«³õ§ó¬O®i²{¥X«e©Ò¥¼¦³ªº°Ê¯à¡A¬°AIªº¥þ²yµo®i±a¨Ó§ó¦h¥i¯à©Ê¡C

¹Ï1. ¦~«×ªÑÅv¿Ä¸ê©M¥æ©ö¡F¡§State of AI, Global | 2024 recap¡¨ ¡ACB Insights

¾ÚCB Insights ªº ¡§State of AI, Global | 2024 recap¡¨ ³ø§i¡]¤UºÙ¡m³ø§i¡n¡^¸ê®ÆÅã¥Ü¡A¦b§ë¸ê¤è­±¡A2024¦~¥þ²yAI¬ÛÃö¥ø·~¦@Àò±o1,004»õ¬ü¤¸ªº§ë¸ê¡A¬°¾ú¥v¤W­º¦¸¬ð¯}¤d»õ¬ü¤¸¤jÃö¡A¸û«e¤@¦~¦³ÅãµÛ¼Wªø¡C§ë¸êªº¥D­nÅX°Ê¤O¨Ó¦Û©ó13µ§¶W¹L10»õ¬ü¤¸ªº¥¨ÃB¥æ©ö¡AÅã¥Ü¥«³õ¹ï AI §Þ³Nªºµo®i©ê«ù°ª«×´Á«Ý¡CµM¦Ó¡A­È±oª`·Nªº¬O¡A³o¨Ç¤j«¬§ë¸ê¨Ã«D¥­§¡¤À¥¬¦b©Ò¦³ªºAI»â°ì¡C¬Û¸û©ó¹L¥hAI¦bª÷¿Ä¬ì§Þ¡B¼Æ¦ì°·±d¡B¹s°âµ¥¯S©w²£·~ªºÀ³¥Î¡A¦p¤µ§ë¸êªÌ§ó¶É¦V©ó¤ä«ùAI°ò¦³]¬I»P³q¥Î§Þ³Nªº¶}µo¡AÅã¥ÜAI²£·~ªº§ë¸êµ²ºc¥¿¦bµo¥ÍÂàÅÜ¡C

¥H2024¦~ªº¼Æ¾Ú¨Ó¬Ý¡AAI ²£·~ªº¦­´Á§ë¸ê¤´µM¥e¾Ú¥D¾É¦a¦ì¡A¨ä¤¤74% ªº¥æ©öµo¥Í¦b¦­´Á¶¥¬q¡AÅã¥Ü¥X§ë¸êªÌ¤´µMÄ@·N¦b©|¥¼¦¨¼ôªºAI§Þ³N¤¤´M§ä¥¼¨ÓªºÀò§Q¾÷·|¡A¦Ó«D¶È±Mª`©ó¤w¸gÅçÃÒ¹Lªº°Ó·~¼Ò¦¡¡C

¥Í¦¨¦¡ AI ¤è¿³¥¼¦ã

¥Í¦¨¦¡AI¨Ì¬O¥«³õªº®Ö¤ßµJÂI¡A±qOpenAI¤ÎxAI ªº¿Ä¸ê³W¼Ò§Y¥i¨£¤@´³¡COpenAI ©ó2024¦~Àò±o66»õ¬ü¤¸§ë¸ê¡A¦ô­È¹F¨ì1,570»õ¬ü¤¸¡Aí§¤AI»â°ìªºÀsÀY¦a¦ì¡C»P¦¹¦P®É¡A¥ÑElon Musk»â¾ÉªºxAI¤]Àò±o60»õ¬ü¤¸ªº¸êª÷¤ä«ù¡A¦ô­È¹F¨ì500»õ¬ü¤¸¡A³oÅã¥Ü¥X¥«³õ¹ï¥Í¦¨¦¡AIªºÃöª`¤w¸g¹F¨ì«e©Ò¥¼¦³ªºµ{«×¡C°£¤F³o¨Ç»â¥ý¥ø·~¤§¥~¡AAI¬ÛÃö°ò¦³]¬Iªºµo®i¥ç¦¨¬°§ë¸ê¤H·sªºÃöª`­«ÂI¡C®Ú¾Ú¡m³ø§i¡n¡A2024¦~³Ì¤jµ§ªº¥æ©ö¤¤¡A¦³4µ§¨Ó¦ÛAI°ò¦³]¬I¥ø·~¡A³o·N¨ýµÛ¥«³õ¤£¶ÈÃöª`AIªºÀ³¥Î³õ´º¡A¤]¶}©l§ë¤J¤j¶q¸êª÷¨Ó¤ä´©AI¼Ò«¬ªº°V½m»P¹B¦æ¡A³o¤]»P·í«eAIµo®i©Ò»Ýªº¤j¶q­pºâ¸ê·½±K¤£¥i¤À¡C

¹Ï2. ¬ü°ê2024 ¦~²Ä 4 ©u«e10¤j³»¯ÅªÑÅv¥æ©ö¡F¡§State of AI, Global | 2024 recap¡¨ ¡ACB Insights

AI ¿W¨¤Ã~»P¥«³õ¦¨¼ô«×

AI¿W¨¤Ã~ªº½Ï¥Í³t«×¦b2024¦~¤j´T´£¤É¡A¥þ¦~·s¼W32®aAI¿W¨¤Ã~¡A¥e©Ò¦³·s¿W¨¤Ã~ªº50%¡AÅã¥ÜAI²£·~ªº§ë¸ê¼ö¼é¤´¥¼´î°h¡CµM¦Ó¡A³o¨ÇAI¿W¨¤Ã~ªº°Ó·~¦¨¼ô«×¤´µM¬Û¹ï¸û§C¡A¼Æ¾ÚÅã¥Ü¡A34%ªºAI¿W¨¤Ã~³B©ó¡uªì¨B¶}µo¡v¶¥¬q¡A¶È¦³3%¹F¨ì¡u³W¼Ò¤ÆÀç¹B¡v¶¥¬q¡A³o¥NªíµÛ¥Ø«eAI²£·~ªº¦ô­È§ó¦h¨Ó¦Û©ó§Þ³Nªº¼ç¤O¡A¦Ó«D²{¶¥¬qí©wªº°Ó·~¼Ò¦¡¡C

»P¶Ç²Î¬ì§Þ¿W¨¤Ã~¬Û¤ñ¡AAI¥ø·~¹F¨ì10»õ¬ü¤¸¦ô­Èªº³t«×ÅãµÛ¥[§Ö¡AAI¥ø·~ªº¥­§¡¦ô­È¦¨ªø®É¶¡¬°2¦~¡A»·§C©ó«DAI¥ø·~ªº9¦~¡A³oÅã¥ÜAI²£·~ªº¦¨ªø°Ê¯à·¥¬°±j«l¡A¦ý¦P®É¤]¥i¯à¦³¼çÂí·ÀI¡A¦]¬°³\¦hAI¥ø·~ªº°Ó·~¼Ò¦¡¤´¥¼§¹¥þ½T¥ß¡A¯à§_¦b¥¼¨Ó«ùÄòÀò§Q¤´¦³«ÝÆ[¹î¡C

AI¨ÖÁÊÁͶÕ

¡m³ø§i¡n«ü¥X¡AAI ²£·~ªº¨ÖÁʬ¡°Ê¦b2024¦~¨Ì¬¡ÅD¡A¥þ¦~¦@µo¥Í384µ§AI¬ÛÃö¨ÖÁÊ¥æ©ö¡A´X¥G»P2023¦~ªº397µ§«ù¥­¡C­È±oÃöª`ªº¬O¡A¼Ú¬w¥«³õªºAI¥ø·~¨ÖÁÊ¥æ©ö¼Æ¶q¹F¨ì¤F136µ§¡A¸û«e¤@¦~¼Wªø¤F7%¡AÅã¥Ü¸Ó¦a°ÏAI¥ø·~ªº¼vÅT¤O¥¿¦b§Ö³t´£¤É¡C

±q¥æ©ö³W¼Ò¨Ó¬Ý¡AAI¥ø·~ªº¨ÖÁʮפ£¥F°ª»ù¦¬ÁʮרҡA¨ä¤¤¥H¦â¦Cªº¤@®aAI¤½¥q¥H13»õ¬ü¤¸¥X°âµ¹Permira¡A¦ÓNVIDIA¤]¥¸¸ê7»õ¬ü¤¸¦¬ÁÊ¥t¤@®a¥H¦â¦CAI¤½¥q¡A¦¹¥~¡AAMD¥ç¥H6.55»õ¬ü¤¸¦¬ÁʤFªâÄõªº¤@®aAI¥ø·~¡C³o¨Ç¤j«¬¨ÖÁÊ®×Åã¥Ü¡AAI§Þ³N¤w¸g¦¨¬°¤j«¬¬ì§Þ¤½¥qª§¬Û§G§½ªº¾Ô²¤­«ÂI¡A³o¨Ç¥ø·~¤£¶È§Æ±æ³z¹L¨ÖÁʨÓÀò¨úAI§Þ³N¡A¤]§Æ±æ¶i¤@¨B¾d©T¦b¥«³õ¤¤ªºÄvª§Àu¶Õ¡C

AI°ò¦³]¬I»P¥¼¨Ó®i±æ

AI°ò¦³]¬Iªº§ë¸ê¦b2024¦~ªï¨Ó¤F¤@ªi°ª®p¡A³o»PAI§Þ³N¥»¨­ªº°ª¹Bºâ»Ý¨D±K¤Á¬ÛÃö¡CAI¼Ò«¬ªº°V½m»PÀ³¥Î»Ý­n¤j¶qªº­pºâ¸ê·½¡A¦]¦¹AI°ò¦³]¬Iªºµo®i¦¨¬°§ë¸êªÌªº·sÃöª`ÂI¡C¹³¬ODatabricksÀò±o100»õ¬ü¤¸§ë¸ê¡A¦ô­È¹F620»õ¬ü¤¸¡A¦¨¬°AI¸ê®Æ³B²z»â°ìªº­«­n¥ø·~¡C¦¹¥~¡ATenstorrent§@¬°AI´¹¤ù¶}µo¤½¥q¡AÀò±o6.93 »õ¬ü¤¸ªº¿Ä¸ê¡AÅã¥ÜAI²£·~ªºµo®i¤w¸g¤£¶È­­©ó³nÅé¼h­±¡A¤]©µ¦ù¦ÜµwÅé»P­pºâ¬[ºc»â°ì¡CÀHµÛ AI ¼Ò«¬³W¼Òªº¤£Â_ÂX¤j¡A¹ï°ª®Ä¯àAI´¹¤ù»P­pºâ°ò¦³]¬Iªº»Ý¨D±N«ùÄò´£¤É¡A¥¼¨ÓAI²£·~ªºÄvª§®æ§½±N¤£¶È¶È§½­­©ó³nÅé¶}µo¡A¦Ó¬O¯A¤Î§ó¼sªxªº§Þ³N¥ÍºA¨t²Î¡C

¡i¥»¤å¥¼§¹¡A§¹¾ã¤º®e½Ð¨£¡m¥_¬ü´¼Åv³ø¡n374´Á¡G±M§Q®v¤½·|ªº¨Ï©R»P¾UÅÜ¡G±M³X·s¥ô²z¨Æªø¯³«ØÃСj

¡°¦p±ýÂà¸ü¥»¤å¡A½Ð»P¥_¬ü´¼Åv³øÁpµ¸

 
 
¥»¹q¤l³øµÛ§@Åv§¡ÄÝ¡uÁp¦X½u¤W¤½¥q¡v©Î±ÂÅv¡uÁp¦X½u¤W¤½¥q¡v¨Ï¥Î¤§¦XªkÅv§Q¤H©Ò¦³¡A
¸T¤î¥¼¸g±ÂÅvÂà¸ü©Î¸`¿ý¡C­Y¹ï¹q¤l³ø¤º®e¦³¥ô¦óºÃ°Ý©Î­n¨DÂà¸ü±ÂÅv¡A½Ð¡i
Ápµ¸§Ú­Ì¡j¡C
  §K¶O¹q¤l³ø | µÛ§@ÅvÁn©ú | Áô¨pÅvÁn©ú | Ápµ¸§Ú­Ì